AMG National Trust Bank’s Starling Oncology STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.3K Hold
10,000
﹤0.01% 444
2026
Q1
$30.7K Hold
10,000
﹤0.01% 476
2025
Q4
$35.6K Hold
10,000
﹤0.01% 452
2025
Q3
$34.9K Hold
10,000
﹤0.01% 452
2025
Q2
$20.5K Hold
10,000
﹤0.01% 446
2025
Q1
$11.4K Hold
10,000
﹤0.01% 441
2024
Q4
$3.09K Hold
10,000
﹤0.01% 447
2024
Q3
$3.27K Hold
10,000
﹤0.01% 440
2024
Q2
$4.6K Buy
+10,000
New +$8.54K ﹤0.01% 442

Other funds holding STLN

AMG National Trust Bank's STLN Position: Q2 2026 in Review

AMG National Trust Bank held its Starling Oncology (STLN) position steady in Q2 2026 at 10,000 shares worth $54.3K. The position accounts for ﹤0.01% of the portfolio, ranked #444.

AMG National Trust Bank first reported a position in STLN in Q2 2024 and has held it in 9 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • AMG National Trust Bank held 10,000 shares of Starling Oncology worth $54.3K as of Q2 2026.
  • AMG National Trust Bank left its Starling Oncology share count unchanged in Q2 2026.
  • Starling Oncology made up ﹤0.01% of AMG National Trust Bank's portfolio in Q2 2026, its #444 holding.
  • AMG National Trust Bank first reported a position in Starling Oncology in Q2 2024 and has held it in 9 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.